GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.4) LIMITED

Active Stevenage

Other service activities n.e.c.

0 employees website.com
Other service activities n.e.c.
G

GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.4) LIMITED

Other service activities n.e.c.

Founded 11 Dec 2018 Active Stevenage, United Kingdom 0 employees website.com
Other service activities n.e.c.
Accounts Submitted 19 Aug 2025 Next due 30 Sept 2026 5 months remaining
Confirmation Submitted 22 Sept 2025 Next due 6 Oct 2026 5 months remaining
Net assets £-1,841M £532M 2024 year on year
Total assets £1,639M £237M 2024 year on year
Total Liabilities £3,480M £770M 2024 year on year
Charges None No charges registered

Contact & Details

Contact

Registered Address

Gsk Medicines Research Centre Gunnels Wood Road Stevenage SG1 2NY United Kingdom

Telephone

0800 000 0000

Email

info@example.com

Website

www.example.com

Full company profile for GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.4) LIMITED (11721880), an active company based in Stevenage, United Kingdom. Incorporated 11 Dec 2018. Other service activities n.e.c.. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type Total Exemption Full
Next accounts 31 December 2025
Due by 30 September 2026 9 months

Net Assets, Total Assets & Total Liabilities (2019–2024)

Cash in Bank

N/A

Net Assets

-£1840.83M

Decreased by £532.20M (-41%)

Total Liabilities

£3480.15M

Increased by £769.56M (+28%)

Turnover

£102.59M

Decreased by £25.53M (-20%)

Employees

N/A

Debt Ratio

212%

Increased by 19 (+10%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
Dec Year End
2023
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Officers

Officers

0 active 3 resigned
Status

No officers found

No officers found

Shareholders

Shareholders (1)

Glaxo Group Limited
100.0%

Persons with Significant Control

Persons with Significant Control (1)

1 Active

Glaxo Group Limited

United Kingdom

Active
Notified 11 Dec 2018
Nature of Control
  • Ownership Of Shares 75 To 100 Percent,voting Rights 75 To 100 Percent,right To Appoint And Remove Directors

Group Structure

Group Structure

GSK PLC united kingdom
GLAXO GROUP LIMITED united kingdom
GLAXO GROUP LIMITED united kingdom
GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.4) LIMITED Current Company

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
22 Sept 2025Confirmation StatementConfirmation statement made on 2025-09-22 with no updates
19 Aug 2025AccountsAnnual accounts filed
19 Aug 2025OtherNotice of agreement to exemption from audit of accounts for period ending 31/12/24
19 Aug 2025OtherAudit exemption statement of guarantee by parent company for period ending 31/12/24
19 Aug 2025AccountsAnnual accounts made up to 2024-12-31
22 Sept 2025 Confirmation Statement

Confirmation statement made on 2025-09-22 with no updates

19 Aug 2025 Accounts

Annual accounts filed

19 Aug 2025 Other

Notice of agreement to exemption from audit of accounts for period ending 31/12/24

19 Aug 2025 Other

Audit exemption statement of guarantee by parent company for period ending 31/12/24

19 Aug 2025 Accounts

Annual accounts made up to 2024-12-31

Recent Activity

Latest Activity

Confirmation statement made on 2025-09-22 with no updates

6 months ago on 22 Sept 2025

Annual accounts filed

8 months ago on 19 Aug 2025

Notice of agreement to exemption from audit of accounts for period ending 31/12/24

8 months ago on 19 Aug 2025

Audit exemption statement of guarantee by parent company for period ending 31/12/24

8 months ago on 19 Aug 2025

Annual accounts made up to 2024-12-31

8 months ago on 19 Aug 2025